When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?
Pancreatic neuroendocrine neoplasms (PanNENs) are rare and heterogeneous diseases that account for less than 2% of all cases of pancreatic cancer and only 30% of digestive neuroendocrine neoplasia, even if their incidence and prevalence continue to rise globally [...]
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-07-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/14/4581 |
| _version_ | 1797588840977793024 |
|---|---|
| author | Matteo Marasco Domenico Galasso Alberto Larghi Francesco Panzuto |
| author_facet | Matteo Marasco Domenico Galasso Alberto Larghi Francesco Panzuto |
| author_sort | Matteo Marasco |
| collection | DOAJ |
| description | Pancreatic neuroendocrine neoplasms (PanNENs) are rare and heterogeneous diseases that account for less than 2% of all cases of pancreatic cancer and only 30% of digestive neuroendocrine neoplasia, even if their incidence and prevalence continue to rise globally [...] |
| first_indexed | 2024-03-11T00:58:48Z |
| format | Article |
| id | doaj.art-8761378e9ea9402cb7f9a9546beee41a |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-11T00:58:48Z |
| publishDate | 2023-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-8761378e9ea9402cb7f9a9546beee41a2023-11-18T19:50:53ZengMDPI AGJournal of Clinical Medicine2077-03832023-07-011214458110.3390/jcm12144581When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?Matteo Marasco0Domenico Galasso1Alberto Larghi2Francesco Panzuto3Digestive Diseases Unit, Sant’Andrea University Hospital, ENETS Center of Excellence, Via di Grottarossa 1035, 00189 Rome, ItalyUnité de Gastro-Entérologie Service de Médicine Interne, Hôpital Riviera-Chablais, 1847 Rennaz, SwitzerlandDigestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, ItalyDigestive Diseases Unit, Sant’Andrea University Hospital, ENETS Center of Excellence, Via di Grottarossa 1035, 00189 Rome, ItalyPancreatic neuroendocrine neoplasms (PanNENs) are rare and heterogeneous diseases that account for less than 2% of all cases of pancreatic cancer and only 30% of digestive neuroendocrine neoplasia, even if their incidence and prevalence continue to rise globally [...]https://www.mdpi.com/2077-0383/12/14/4581n/a |
| spellingShingle | Matteo Marasco Domenico Galasso Alberto Larghi Francesco Panzuto When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? Journal of Clinical Medicine n/a |
| title | When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? |
| title_full | When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? |
| title_fullStr | When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? |
| title_full_unstemmed | When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? |
| title_short | When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors? |
| title_sort | when should we adopt eus guided radiofrequency ablation in pancreatic neuroendocrine tumors |
| topic | n/a |
| url | https://www.mdpi.com/2077-0383/12/14/4581 |
| work_keys_str_mv | AT matteomarasco whenshouldweadopteusguidedradiofrequencyablationinpancreaticneuroendocrinetumors AT domenicogalasso whenshouldweadopteusguidedradiofrequencyablationinpancreaticneuroendocrinetumors AT albertolarghi whenshouldweadopteusguidedradiofrequencyablationinpancreaticneuroendocrinetumors AT francescopanzuto whenshouldweadopteusguidedradiofrequencyablationinpancreaticneuroendocrinetumors |